Pharmacological treatment of depression
266 results
1 - 100
Pharmacological treatment for psychotic depression- Pharmacologic treatment of depression in multiple sclerosis
- Pharmacological interventions for treatment‐resistant depression in adults
- Pharmacological treatment of depression in people with a primary brain tumour
- Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
- Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
- Psychological and pharmacological interventions for depression in patients with coronary artery disease
- Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression: Cochrane systematic review
- Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke
- Pharmacological, psychological and non‐invasive brain stimulation interventions for preventing depression after stroke
- Prevention of depression in adults with long‐term physical conditions
- Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression
- Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults
- Non‐pharmacological interventions for depression in adults and children with traumatic brain injury
- Brexpiprazole versus placebo or other antidepressive agents for treating depression
- Pharmacological interventions for self‐harm in adults
- Acupuncture for depression
- Pharmacological interventions for self‐harm in adults
- Exercise for depression
- Psychosocial and psychological interventions for treating postpartum depression
- Amitriptyline for depression
- Pharmacological interventions for the treatment of disordered and problem gambling
- Duloxetine versus other anti‐depressive agents for depression
- Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Fluvoxamine versus other anti‐depressive agents for depression
- Tricyclic drugs for depression in children and adolescents
- Psychostimulants for depression
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome
- Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents
- Interventions for fear of childbirth including tocophobia
- Escitalopram versus other antidepressive agents for depression
- Pharmacological treatment for Kleine‐Levin syndrome
- Pharmacological interventions for somatoform disorders in adults
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- Mirtazapine versus other antidepressive agents for depression: Cochrane systematic review
- Vortioxetine for depression in adults
- Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review
- Non‐pharmacological interventions for improving language and communication in people with primary progressive aphasia
- Antidepressant treatment for postnatal depression
- Bright light therapy for sleep problems in adults aged 60+
- Sertraline versus other antidepressive agents for depression
- Antidepressants for people with both schizophrenia and depression
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence: Cochrane systematic review
- Interventions for fatigue in people with kidney failure requiring dialysis
- Brexanolone, zuranolone and related neurosteroid GABAA receptor positive allosteric modulators for postnatal depression
- Risperidone in long‐term treatment for bipolar disorder
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Pharmacologic interventions for treating phantom limb pain
- Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes
- Consultation liaison in primary care for people with mental disorders
- Music therapy for depression
- Antidepressants for cocaine dependence and problematic cocaine use: Cochrane systematic review
- Interventions for preventing relapse or recurrence of major depressive disorder in adults in a primary care setting: a network meta‐analysis
- Interventions for the management of fatigue in adults with a primary brain tumour
- Behavioural activation therapy for depression in adults with non‐communicable diseases
- Non‐pharmacological interventions for chronic pain in people with spinal cord injury
- Psychosocial and psychological interventions for treating antenatal depression
- Antidepressants for treating depression in adults with end‐stage kidney disease treated with dialysis
- Non-pharmacological interventions for fatigue in rheumatoid arthritis: Cochrane systematic review
- Pharmacological and non‐pharmacological treatments for impulsive‐compulsive behaviors in Parkinson's disease
- Milnacipran versus other antidepressive agents for depression
- Pharmacological interventions for unilateral spatial neglect after stroke